Nicholas Borcherding

6.0k total citations · 2 hit papers
77 papers, 2.7k citations indexed

About

Nicholas Borcherding is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Nicholas Borcherding has authored 77 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 33 papers in Molecular Biology and 32 papers in Immunology. Recurrent topics in Nicholas Borcherding's work include Immune Cell Function and Interaction (14 papers), Cancer Immunotherapy and Biomarkers (13 papers) and T-cell and B-cell Immunology (10 papers). Nicholas Borcherding is often cited by papers focused on Immune Cell Function and Interaction (14 papers), Cancer Immunotherapy and Biomarkers (13 papers) and T-cell and B-cell Immunology (10 papers). Nicholas Borcherding collaborates with scholars based in United States, China and Australia. Nicholas Borcherding's co-authors include Weizhou Zhang, Jonathan R. Brestoff, Praveen Vikas, Ryan Kolb, Rohan Garje, Andrew P. Voigt, Adithya Chennamadhavuni, Guang‐Hui Liu, Andrew M. Bellizzi and Ajaykumar Vishwakarma and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Nicholas Borcherding

74 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The power and potential of mitochondria transfer

2023 236 citations Nicholas Borcherding, Jonathan R. Brestoff profile →
Mapping the immune environment in clear cell renal carcinoma by single-cell genomics

2021 188 citations Nicholas Borcherding, Andrew P. Voigt et al. Communications Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas Borcherding United States	28	1.3k	923	773	467	343	77	2.7k
Camelia Quek Australia	16	1.3k 1.0×	937 1.0×	826 1.1×	582 1.2×	254 0.7×	37	2.5k
Jay Friedman United States	27	834 0.6×	1.2k 1.3×	1.1k 1.4×	355 0.8×	342 1.0×	55	2.6k
Yasuto Akiyama Japan	27	878 0.7×	937 1.0×	708 0.9×	332 0.7×	270 0.8×	128	2.2k
Yong Lu United States	24	949 0.7×	1.0k 1.1×	1.3k 1.7×	512 1.1×	275 0.8×	53	2.6k
Laura S. Angelo United States	19	981 0.8×	985 1.1×	696 0.9×	294 0.6×	173 0.5×	29	2.1k
Navid Shomali Iran	28	1.1k 0.8×	1.0k 1.1×	726 0.9×	611 1.3×	178 0.5×	78	2.6k
Martin S. Staege Germany	23	1.4k 1.1×	669 0.7×	842 1.1×	356 0.8×	356 1.0×	108	2.7k
Shengyong Yin China	27	1.3k 1.0×	879 1.0×	547 0.7×	603 1.3×	240 0.7×	78	2.7k
Carsten Weishaupt Germany	21	948 0.7×	1.3k 1.5×	863 1.1×	327 0.7×	171 0.5×	61	2.6k
Ye Zhou China	30	1.9k 1.5×	711 0.8×	763 1.0×	961 2.1×	357 1.0×	98	3.3k

Countries citing papers authored by Nicholas Borcherding

Since Specialization

Citations

This map shows the geographic impact of Nicholas Borcherding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Borcherding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Borcherding more than expected).

Fields of papers citing papers by Nicholas Borcherding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Borcherding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Borcherding. The network helps show where Nicholas Borcherding may publish in the future.

Co-authorship network of co-authors of Nicholas Borcherding

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Borcherding. A scholar is included among the top collaborators of Nicholas Borcherding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Borcherding. Nicholas Borcherding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Borcherding, Nicholas, Adam J. Rauckhorst, Wade R. Gutierrez, et al.. (2025). Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTs. Science Advances. 11(33). eadu2906–eadu2906.

Rogers, Kai J., et al.. (2025). Myelin-reactive CD8+ T cells influence conventional dendritic cell subsets towards a mature and regulatory phenotype in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 22(1). 54–54. 1 indexed citations

Kim, Myung‐Chul, Umasankar De, Nicholas Borcherding, et al.. (2024). Single-cell transcriptomics unveil profiles and interplay of immune subsets in rare autoimmune childhood Sjögren’s disease. Communications Biology. 7(1). 481–481. 4 indexed citations

Field, Rachael L., Rocky Giwa, Wentong Jia, et al.. (2024). Mitochondria transfer-based therapies reduce the morbidity and mortality of Leigh syndrome. Nature Metabolism. 6(10). 1886–1896. 22 indexed citations

Borcherding, Nicholas, et al.. (2023). Molecular techniques drive cutting edge advancements in management of cutaneous T cell lymphoma. Frontiers in Immunology. 14. 1228563–1228563. 1 indexed citations

Herzog, Brett H., John Baer, Nicholas Borcherding, et al.. (2023). Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non–small cell lung cancer. Science Translational Medicine. 15(699). eadh8005–eadh8005. 44 indexed citations

Crawford, Michael P., Nicholas Borcherding, & Nitin J. Karandikar. (2023). IL-17 cytokines preferentially act on naïve CD4+ T cells with the IL-17AF heterodimer inducing the greatest functional changes. PLoS ONE. 18(4). e0285166–e0285166. 3 indexed citations

Lander, Varintra E., Jad I. Belle, Natalie L. Kingston, et al.. (2022). Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade. Cancer Discovery. 12(12). 2774–2799. 66 indexed citations

Reynolds, Daniel, Cristina Vazquez Guillamet, Nicholas Borcherding, et al.. (2021). Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19. The Journal of Immunology. 207(5). 1229–1238. 26 indexed citations

10.

Fujiwara, Yuki, Robert J. Torphy, Yi Sun, et al.. (2021). The GPR171 pathway suppresses T cell activation and limits antitumor immunity. Nature Communications. 12(1). 5857–5857. 19 indexed citations

11.

Kolb, Ryan, Umasankar De, Sajid Khan, et al.. (2021). Proteolysis-targeting chimera against BCL-XL destroys tumor-infiltrating regulatory T cells. Nature Communications. 12(1). 1281–1281. 42 indexed citations

12.

Borcherding, Nicholas, et al.. (2021). Understanding and Targeting Human Cancer Regulatory T Cells to Improve Therapy. Advances in experimental medicine and biology. 1278. 229–256. 6 indexed citations

13.

Borcherding, Nicholas, Yogesh Jethava, & Praveen Vikas. (2020). Repurposing Anti-Cancer Drugs for COVID-19 Treatment. SHILAP Revista de lepidopterología. 4 indexed citations

14.

Cho, Edward H., Nicholas Borcherding, Mikhail V. Kulak, et al.. (2020). AP-2γ Is Required for Maintenance of Multipotent Mammary Stem Cells. Stem Cell Reports. 16(1). 106–119. 6 indexed citations

15.

Borcherding, Nicholas, Andrew P. Voigt, Vincent Liu, et al.. (2019). Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression. Clinical Cancer Research. 25(10). 2996–3005. 88 indexed citations

16.

Beck, Anna C., Nicholas Borcherding, Tiandao Li, et al.. (2019). A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer. Molecular Cancer Research. 18(1). 46–56. 13 indexed citations

17.

Kulak, Mikhail V., et al.. (2017). A novel HER2 gene body enhancer contributes to HER2 expression. Oncogene. 37(5). 687–694. 39 indexed citations

18.

Kolb, Ryan, Liem Phan, Nicholas Borcherding, et al.. (2016). Obesity-associated NLRC4 inflammasome activation drives breast cancer progression. Nature Communications. 7(1). 13007–13007. 187 indexed citations

19.

Borcherding, Nicholas, Ryan Kolb, Qing Xie, et al.. (2015). Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating Cells. Cancer Research. 75(10). 1972–1982. 46 indexed citations

20.

Borcherding, Nicholas, et al.. (2013). Dietary Resistant Starch Prevents Urinary Excretion of 25-Hydroxycholecalciferol and Vitamin D-Binding Protein in Type 1 Diabetic Rats1,2. Journal of Nutrition. 143(7). 1123–1128. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact